These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7703379)

  • 21. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
    Stell D; Marshall H; Bradley JA; Bolton EM
    Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
    Ruiz P; Coffman TM; Howell DN; Straznickas J; Scroggs MW; Baldwin WM; Klotman PE; Sanfilippo F
    Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.
    Waaga AM; Gasser M; Kist-van Holthe JE; Najafian N; Müller A; Vella JP; Womer KL; Chandraker A; Khoury SJ; Sayegh MH
    J Clin Invest; 2001 Apr; 107(7):909-16. PubMed ID: 11285310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
    Qin L; Ding Y; Tahara H; Bromberg JS
    J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral exposure to alloantigen generates intragraft CD8+ regulatory cells.
    Zhou J; Carr RI; Liwski RS; Stadnyk AW; Lee TD
    J Immunol; 2001 Jul; 167(1):107-13. PubMed ID: 11418638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig.
    Perico N; Imberti O; Bontempelli M; Remuzzi G
    Kidney Int; 1995 Jan; 47(1):241-6. PubMed ID: 7731152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
    Tanaka K; Turka LA; Kupiec-Weglinski JW; Milford EL; Ueda H; Diamantstein T; Carpenter CB; Tilney NL
    Transplantation; 1990 Jul; 50(1):125-31. PubMed ID: 2142344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K; Lehmann M; Akalin E; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 1996 Sep; 157(5):1944-50. PubMed ID: 8757313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of antibody in rat renal allograft rejection. I. Absence of antibody to erythrocyte-associated antigens is associated with enhanced renal allograft survival.
    Majoor GD; van de Gaar MJ; Vlek LF; van Breda Vriesman PJ
    Transplantation; 1981 May; 31(5):369-75. PubMed ID: 7015624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
    Asakura H; Takayashiki T; Ku G; Flye MW
    Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
    Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
    Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H; Wei RQ; Goodman RE; Bolling SF
    Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and function of suppressor T lymphocytes in immunologically unresponsive rats following pretreatment with UV-B-irradiated donor leukocytes and peritransplant cyclosporine.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplantation; 1989 Jun; 47(6):1001-7. PubMed ID: 2525288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression.
    Ke B; Coito AJ; Kato H; Zhai Y; Wang T; Sawitzki B; Seu P; Busuttil RW; Kupiec-Weglinski JW
    Transplantation; 2000 Apr; 69(8):1690-4. PubMed ID: 10836382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stable prodrugs of n-butyric acid: suppression of T cell alloresponses in vitro and prolongation of heart allograft survival in a fully allogeneic rat strain combination.
    Böhmig GA; Krieger PM; Säemann MD; Ullrich R; Karimi H; Wekerle T; Mühlbacher F; Zlabinger GJ
    Transpl Immunol; 1999 Dec; 7(4):221-7. PubMed ID: 10638835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
    Salom RN; Maguire JA; Hancock WW
    Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.